Vehicle (Placebo solution)

DRUG5 trials

Sponsors

Dompé Farmaceutici S.p.A, Taejoon Pharmaceutical Co., Ltd., Access Business Group

Conditions

Dry Eye DiseaseDry Eye Syndrome (DES)MyopiaOral Health Related Quality of Life (OHRQoL)Presbyopia

Phase 2

A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease.

CompletedNCT06244316

Dompé Farmaceutici S.p.ADry Eye Disease

Start: 2024-01-22End: 2024-12-04Updated: 2026-02-13

Evaluate the Safety and Efficacy of TJO-087

Active, not recruitingNCT07810972

Taejoon Pharmaceutical Co., Ltd.Dry Eye Syndrome (DES)

Start: 2026-04-06End: 2026-12-01Updated: 2026-09-09

Phase 3

Evaluate the Efficacy and Safety of CTO0307 in Adults With Presbyopia

CompletedNCT07723716

Taejoon Pharmaceutical Co., Ltd.Presbyopia

Start: 2025-02-26End: 2025-09-25Updated: 2026-08-28

Evaluate the Efficacy and Safety of CTO0308 in Pediatric Patients With Myopia

Active, not recruitingNCT07790640

Taejoon Pharmaceutical Co., Ltd.Myopia

Start: 2025-08-11End: 2027-09-01Updated: 2026-09-01

Unknown Phase

New Functional Ingredient for Oral Care

Not yet recruitingNCT07771907

Access Business GroupOral Health Related Quality of Life (OHRQoL)

Start: 2026-09-01End: 2027-03-01Target: 100Updated: 2026-08-19